title: Do we have sufficient information to optimally inform regulatory or other policy decisions about medications containing codeine?
authors.affiliation: Alcohol, Tobacco and Other Drug Research Unit, Medical Research Council, Cape Town, South Africa. cparry@mrc.ac.za.|Department of Psychiatry, Stellenbosch University, Stellenbosch, South Africa. cparry@mrc.ac.za.
authors.forename: Charles D H
authors.initials: CD
authors.lastname: Parry
authors.affiliation: Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
authors.forename: Paolo
authors.initials: P
authors.lastname: Deluca
authors.affiliation: School of Health and Related Research, University of Sheffield, Sheffield, UK.
authors.forename: Richard
authors.initials: R
authors.lastname: Cooper
authors.affiliation: School of Health Sciences, Waterford Institute of Technology, Waterford, Ireland.
authors.forename: Marie Claire
authors.initials: MC
authors.lastname: Van Hout
mesh_terms: D000701:Analgesics, Opioid / Q000627:therapeutic use*; D003061:Codeine / Q000627:therapeutic use*; D003657:Decision Making; D004335:Drug and Narcotic Control; D006291:Health Policy; D006801:Humans; D004366:Nonprescription Drugs; D009293:Opioid-Related Disorders / Q000453:epidemiology*; D011050:Policy Making; D013019:South Africa
chemical_list: D000701:Analgesics, Opioid; D004366:Nonprescription Drugs; D003061:Codeine
keywords: Codeine; Ireland; South Africa; UK; opioid analgesics; over-the-counter and prescription medicines